Figure 6.

Effects of WXKL on the incidence of cardiac arrhythmias in vivo. (a) The ECG recordings from the four experimental groups following an intraperitoneal injection of ISO (3 mg/kg body weight). (b) Detailed tracings for the respective arrhythmic events. (c) WXKL treatment significantly reduced cardiac arrhythmias in vivo compared with the MI group and the amiodarone group (*P < 0.05 versus the MI group, ^▲ P < 0.05 versus the sham group, and ^# P < 0.05 the amiodarone group versus the WXKL group, using Fisher's 2-sided exact test, 6 rats were analysed per group).